1 |
Akbulut, H., Zhang, L., Tang, Y., and Deisseroth, A. (2003). Cytotoxic effect of replication-competent adenoviral vectors carrying L-plastin promoter regulated E1A and cytosine deaminase genes in cancers of the breast, ovary and colon. Cancer Gene Ther. 10, 388-395
DOI
ScienceOn
|
2 |
Akbulut, H., Tang, Y., Maynard, J., Zhang, L., Pizzomo, G., and Deisseroth, A. (2004). Vector targeting makes 5-fluorouracil chemotherapy less toxic and more effective in animal models of epithelial neoplasms. Clin. Cancer Res. 10, 7738-7746
DOI
ScienceOn
|
3 |
Anderson, L., Kilstrup, M., and Neuhard, J. (1989). Pyrimidine, purine and nitrogen conrol of cytosine deaminase synthesis in Escherichia coli K12. Involvement of the glinG and purR genes in the resgulation of codA expression. Arch. Microbial. 152, 115-118
DOI
ScienceOn
|
4 |
Armstrong, R. D., Lewis, M., Stem, S. G., and Cadman, E. C. (1986). Acute effect of 5-fluorouracil on cytoplasmic and nuclear dihydrofolate reductase messenger RNA metabolism. J. Biol. Chem. 261, 7366-7371
|
5 |
Austin, E. A., and Huber, B. E. (1993). A first step in the development of gene therapy for colorectal carcinoma: cloning, sequencing, and expression of E. coli cytosine deaminse. Mol. Pharmacol. 43, 380-387
|
6 |
Bergelson, J. M., Cunningham, J. A., Droguett, G., Kurt-Jones, E. A., Krithivas, A., Hong, J. S., Horwitz, M. S., Crowell, R. L., and Finberg, R. W. (1997). Isolation of a common receptor for cosackie B viruses and adenoviruses 2 and 5. Science. 275, 1320-1323
DOI
|
7 |
Garcia-Sanchez, F., Pizzorno, G., Fu, S. Q., Nanakom, T., Krause, D. S., Liang, J., Adams, E., Leffert, J. J., Yin, L. H., Cooperberg, M. R., Hanania, E., Wang, W. .L., Won, J. H., Peng, X. Y., Cote, R., Brown, R., Burtness, B., Giles, R., Crystal, R., and Deisseroth, A. B. (1998). Cytosine deaminase adenoviral vector and 5-fluorocytosine selectively reduce breast cancer cells 1 million-fold when they contaminate hematopoietic cells: a potential purging method for autologous transplantation. Blood 92, 672-682
|
8 |
Graham, F. L., and Prevec, L. (1991). Manipulation of adenovirus vectors, Methods in molecular biology, Vol. 7, p109-128, E. J. Murray, The Human Press Inc., Clifton, NJ
|
9 |
Hirschowitz, E. A., Ohwada, A, Pascal, W. R., Russi, T. J., and Crystal, R. G. (1995). In vivo adenovirus-mediated gene transfer of the Escherichia coli cytosine deaminase gene to human colon carcinoma-derived tumors induces chemosensitivity to 5-fluorocytosine. Hum. Gene Ther. 6, 1055-1063
DOI
ScienceOn
|
10 |
Huber, B. E., Austin, E. A., Good, S. S., Knick, V. C., Tibbels, S., and Richards, C. A., (1993). In vivo antitumor activity of 5-fluorocytosine on human colorectal carcinoma cells genetically codified to express cytosine deaminase. Cancer Res. 3, 4619-4626
|
11 |
Kievit, E., Nyati, M. K., Ng, E., Stegman, L. D., Parsels, J., Ross, B. D., Rehemtulla, A., and Lawrence, T. S. (2000). Yeast cytosine deaminase improves radiosensitization and bystander effect by 5-fluorocytosine of human colorectal cancer xenografts. Cancer Res. 60, 6649-6655
|
12 |
Kufe, D. W., and Major, P. P. (1981). 5-Fluorouracil incorporation into human breast carcinoma RNA correlates with cytotoxicity. J. Biol. Chem. 256, 9802-9805
|
13 |
Leavitt, J. (1994). Discovery and characterization of two novel huamn cancer-related proteins using two-dimensional gel electrophoresis. Electrophoresis 15, 345-357
DOI
ScienceOn
|
14 |
Peng, X. Y., Won, J. H., Rutherford, T., Fujii, T., Zelterman, D., Pizzorno, G., Sapi, E., Leavitt, J., Kacinski, B., Crystal, R., Schwartz, P., and Deisseroth, A. (2001). The use of the L-plastin promoter for adenoviral-mediated, tumor-specific gene expression in ovarian and bladder cancer cell lines. Cancer Res. 61, 4405-4413
|
15 |
Lin, C.-S., Chen, Z. P., Park, T., Ghosh, K., and Leavitt, J. (1993a). Characterization of the human L-plastin gene promoter in normal and neoplastic cells. J. Biol. Chem. 268, 2793-2801
|
16 |
Lin, C.-S., Park, T., Chen, Z. P., and Leavitt, J. L. (1993b). Human plastin genes. J. Biol. Chem. 268, 2781-2792
|
17 |
Moolten, F. L. (1994). Drug sensitivity (suicide) genes for selective cancer chemotherapy. Cancer Gene Ther. 1, 279-287
|
18 |
Pritchard, D. M., Watson, A. J., Potten, C. S., Jackman, A. L., and Hickman, J. A. (1997). Inhibition by uridine but not thymidine fo p53-dependent intestinal apoptosis initiated by 5-fluorouracil: evidence for the involvement of RNA perturbation. Proc. Natl. Acad. Sci. USA 94, 1795-1799
|
19 |
Wickham, T. J., Mathias, P., Cheresh, D. A., and Nemerow, G. (1993). Integrins and promote adenovirus internalization but not virus attachment. Cell. 73, 309-319
DOI
ScienceOn
|
20 |
Wickham, T. J., Filardo, E. J., Cheresh, D. A., and Nemerow, G. R. (1994). Integrin selectively promotes adenovirus mediated cell membrane permeabilization. J. Cell. Biol. 127, 257-264
DOI
ScienceOn
|
21 |
Zhang, L., Akbulut, H., Tang, Y., Peng, X., Pizzorno, G, Sapi, E., Manegold, S., and Deisseroth, A. (2002). Adenoviral vectors with E1A regulated by tumor-specific promoters are selectively cytolytic for breast cancer and melanoma. Mol. Ther. 6, 386-393
DOI
ScienceOn
|
22 |
Cannistra, S. A. (1995). Cancer of the ovary. N. Engl. J. Med. 329, 1550-1559
DOI
ScienceOn
|
23 |
Chung, I., and Deisseroth, A. B. (2004). Recombinant adenoviral vector containing tumor-specific L-plastin promoter fused to cytosine deaminase gene as a transcription unit: generation and functional test. Arch. Pharm. Res. 27, 633-639
DOI
ScienceOn
|
24 |
Higashiyama, M., Kodama, K., Yokouchi, H., Takami, K., Doi, O., Kobayashi, H., Tanisaka, K., and Minamigawa, K. (1998). Immunohistochemical p53 protein status in nonsmall cell lung cancer is a promising indicator in dterrnining in vitro chemosensitivity to some anticancer drugs. J. Surg. Oncol. 68, 19-24
DOI
ScienceOn
|
25 |
Goldman, M. J., and Wilson, J. M. (1995). Expression of and integrin is necessary for efficient adenovirus-mediated gene transfer in the human airway. J. Virol. 69, 5951-5958
|
26 |
Chung, I., Schwartz, P. E., Crystal, R. G., Pizzomo, G., Leavitt, J. L., and Deisseroth, A. B. (1999). Use of L-plastin promoter to develop adenoviral system which confers transgene expression in ovarian cancer cells but not in normal mesothelial cells. Cancer Gene Ther. 6, 99-106
DOI
ScienceOn
|
27 |
Glazer, R. I., and Lloyd, L. S. (1982). Association of cell lethality with incorporation of 5-fluorouracil and 5-fluoridine into nuclear RNA in human colon carcinoma cells in culture. Mol. Pharmacol. 21, 468-473
|
28 |
Lenz, H. J., Hayashi, K., Salonga, D., Danenberg, K. D., Danenberg, P. V., Metzger, R., Banerjee, D., Bertino, J. R., Groshen, S., Leichman, L. P., and Leichman, C. G. (1998). p53 point mutations and thymidylate synthase messenger RNA levels in disseminated colorectal cancer: an analysis of response and survival. Clin. Cancer Res. 4, 1243-1250
|